A comparison of duration of first prescribed insulin therapy in uncontrolled type 2 diabetes

Diabetes Research and Clinical Practice

Volumn 94, Issue 3, 2011, Pages 442-448

  Hall, G C ^a   McMahon, A D ^b   Dain, M P ^c   Home, P D ^d  

^a Grimsdyke House   (United Kingdom)

^b GLASGOW DENTAL HOSPITAL AND SCHOOL   (United Kingdom)

^c SANOFI   (France)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Insulin; Therapy; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN DETEMIR; INSULIN GLARGINE; ISOPHANE INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGE; AGED; ANGINA PECTORIS; ARTICLE; BODY MASS; CARDIOVASCULAR PROCEDURES; CARDIOVASCULAR RISK; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY PROCEDURE; DISEASE DURATION; DRUG SUBSTITUTION; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRESCRIPTION; RISK FACTOR; SMOKING; TRANSIENT ISCHEMIC ATTACK; TREATMENT DURATION; VASCULAR DISEASE;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCAGON-LIKE PEPTIDES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN, LONG-ACTING; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 82955236071     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2011.09.003     Document Type: Article

References (12)

1. National Institute for Health and Clinical Excellence. Type 2 diabetes: newer agents. 2009 [accessed September 2009]. http://www.nice.org.uk/nicemedia/pdf/CG87ShortGuideline.pdf.
2. Goudswaard A.N., Furlong N.J., Valk G.D., Stolk R.P., Rutten G.E.H.M. Insulin monotherapy versus combinations of insulin with oral hypoglycaemic agents in patients with type 2 diabetes mellitus. Cochrane Database Syst Rev 2004, (4):CD003418.
3. Pfohl M., Dippel F.W., Kostev K., Maltz A., Kotowa W. Lãngere Verweildauer unter einer basalunterstutzten oralen Therapie mit Insulin Glargin (BOT) im Vergleich zu einer Kombinationstherapie aus NPH-Insulin und oralen Antidiabetika. Diabetologie 2009, 4:166-171.
4. Gordon P., McEwan P., Home P. Persistence of the use of initially prescribed basal insulin therapies by people with type 2 diabetes (T2DM). Diabetes 2009, 58:A148-A149.
5. Cooke C.E., Lee H.Y., Tong Y.P., Haines S.T. Persistence with injectable antidiabetic agents in members with type 2 diabetes in a commercial managed care organization. Curr Med Res Opin 2010, 26:231-238.
6. Lewis J.D., Schinnar R., Bilker W.B., Wang X., Strom B.L. Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007, 16:393-401.
7. NHS, Centre for Coding and Classification The READ codes version 3 1996, Stationary Office, London.
8. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
9. Levey A.S., Coresh J., Balk E., Kausz A.T., Levin A., Steffes M.W., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 2003, 139:137-147.
10. Home P.D., Fritsche A., Schinzel S., Massi-Benedetti M. Meta-analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine. Diabetes Obes Metab 2010, 12:772-779.
11. Quinzler R. Persistence with basal supported oral therapy - comparison of insulin glargine versus NPH insulin. Value Health 2009, 12(7):A234. [Abstract].
12. Meneghini L.F., Rosenberg K.H., Koenen C., Merilainen M.J., Luddeke H.J. Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICTIVE study. Diabetes Obes Metab 2007, 9:418-427.